These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25515435)

  • 1. Warfarin and boceprevir interaction causing subtherapeutic international normalized ratio: a case report.
    Tsiattalos AS; Patel A
    J Med Case Rep; 2014 Dec; 8():433. PubMed ID: 25515435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased warfarin requirements in a patient with chronic hepatitis C infection receiving sofosbuvir and ribavirin.
    Peterson D; Van Ermen A
    Am J Health Syst Pharm; 2017 Jun; 74(12):888-892. PubMed ID: 28596225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of a clinically significant interaction between warfarin and intravesical gemcitabine.
    Kurtzhalts K; Gee ME; Feuz L; Krajewski KC
    Am J Health Syst Pharm; 2016 Oct; 73(19):1508-11. PubMed ID: 27646812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Successful Chronic Hepatitis C Virus Treatment with Ledipasvir/Sofosbuvir on Warfarin Dosing Requirements in Four Veterans.
    Britnell SR; Willets AE; Vanderman AJ; Woodard CL; Britt RB
    Pharmacotherapy; 2016 Nov; 36(11):1173-1179. PubMed ID: 27716978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potential interaction between warfarin and atovaquone.
    Hidalgo K; Lyles A; Dean SR
    Ann Pharmacother; 2011 Jan; 45(1):e3. PubMed ID: 21189363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated International Normalized Ratio associated with concurrent use of sorafenib and warfarin.
    Moretti LV; Montalvo RO
    Am J Health Syst Pharm; 2009 Dec; 66(23):2123-5. PubMed ID: 19923313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased warfarin sensitivity among patients treated with elbasvir and grazoprevir for hepatitis C infection.
    DeCarolis DD; Chen YC; Westanmo AD; Conley C; Gravely AA; Khan FB
    Am J Health Syst Pharm; 2019 Sep; 76(17):1273-1280. PubMed ID: 31418789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between gemfibrozil and warfarin: case report and review of the literature.
    Dixon DL; Williams VG
    Pharmacotherapy; 2009 Jun; 29(6):744-8. PubMed ID: 19476425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial.
    Kwo PY; Lawitz EJ; McCone J; Schiff ER; Vierling JM; Pound D; Davis MN; Galati JS; Gordon SC; Ravendhran N; Rossaro L; Anderson FH; Jacobson IM; Rubin R; Koury K; Pedicone LD; Brass CA; Chaudhri E; Albrecht JK;
    Lancet; 2010 Aug; 376(9742):705-16. PubMed ID: 20692693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oseltamivir-warfarin interaction in hypoplastic left heart syndrome: case report and review.
    Wagner J; Abdel-Rahman SM
    Pediatrics; 2015 May; 135(5):e1333-6. PubMed ID: 25917992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated international normalized ratio associated with use of dronedarone and warfarin.
    Pogge EK; Haber SL
    Ann Pharmacother; 2011 Sep; 45(9):e46. PubMed ID: 21811004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.
    Knudsen JF; Sokol GH
    Pharmacotherapy; 2008 Apr; 28(4):540-8. PubMed ID: 18363538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced anticoagulant effect of warfarin in a patient treated with cloxacillin.
    Marusic S; Gojo-Tomic N; Bacic-Vrca V; Franic M
    Int J Clin Pharmacol Ther; 2012 Jun; 50(6):431-3. PubMed ID: 22677303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient case: impact of smoking cessation on international normalized ratio.
    Jordan SD; Stone MD; Alexander E; Haley J; McKee A
    J Pharm Pract; 2014 Oct; 27(5):470-3. PubMed ID: 24395009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between warfarin and nafcillin: case report and review of the literature.
    Kim KY; Frey RJ; Epplen K; Foruhari F
    Pharmacotherapy; 2007 Oct; 27(10):1467-70. PubMed ID: 17896903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experience.
    Coilly A; Roche B; Dumortier J; Leroy V; Botta-Fridlund D; Radenne S; Pageaux GP; Si-Ahmed SN; Guillaud O; Antonini TM; Haïm-Boukobza S; Roque-Afonso AM; Samuel D; Duclos-Vallée JC
    J Hepatol; 2014 Jan; 60(1):78-86. PubMed ID: 23994384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
    Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
    Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in international normalized ratio after smoking cessation in a patient receiving warfarin.
    Evans M; Lewis GM
    Pharmacotherapy; 2005 Nov; 25(11):1656-9. PubMed ID: 16232028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP2C9-mediated warfarin and milk thistle interaction.
    Lash DB; Ward S
    J Clin Pharm Ther; 2020 Apr; 45(2):368-369. PubMed ID: 31633199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated International Normalized Ratio values in a patient receiving warfarin and ceftaroline.
    Farhat NM; Hutchinson LS; Peters M
    Am J Health Syst Pharm; 2016 Jan; 73(2):56-9. PubMed ID: 26721534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.